Drug Database
Back to search

Poland· PL-100317700

Vokanamet

A metformin and canagliflozin product containing canagliflozinum + metformini hydrochloridum, registered in Poland by Janssen-Cilag International N.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A10BD16

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVokanametATCA10BD16REGISTER NO.PL-100317700PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about canagliflozinum + metformini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and canagliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BD16 (metformin and canagliflozin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search metformin and canagliflozin products by name

Metformin and canagliflozin · ATC A10BD16

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Canagliflozinum + Metformini hydrochloridum
Manufacturer
Janssen-Cilag International N.V.
Country
Poland (PL)
ATC code
A10BD16
ATC class
Metformin and canagliflozin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991142254
  • gtin
    05909991142247
  • gtin
    05909991142261

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for metformin and canagliflozin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and canagliflozin against other medicinesHow interaction checks work

Metformin and canagliflozin · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and canagliflozin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and canagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Vokanamet
  • Liechtenstein · Vokanamet
  • Norway · Vokanamet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5c2270fb-c481-4c88-a1a9-18cfc0439e97
GET /v1/drugs/5c2270fb-c481-4c88-a1a9-18cfc0439e97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "150 mg + 1000 mg",
  "packaging": "05909991142254 ¦ Rp ¦ EU/1/14/918/011 ¦ 92071\n60 tabl.\n05909991142247 ¦ Rp ¦ EU/1/14/918/010 ¦ 92072\n20 tabl.\n05909991142261 ¦ Rp ¦ EU/1/14/918/012 ¦ 92073\n180 tabl.",
  "substance": "Canagliflozinum 150 mg + Metformini hydrochloridum 1000 mg",
  "common_name": "Canagliflozinum + Metformini hydrochloridum",
  "pl_product_id": "100317700",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about metformin and canagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console